0001104659-22-026879.txt : 20220224
0001104659-22-026879.hdr.sgml : 20220224
20220224212516
ACCESSION NUMBER: 0001104659-22-026879
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220222
FILED AS OF DATE: 20220224
DATE AS OF CHANGE: 20220224
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: DEC TIMOTHY C
CENTRAL INDEX KEY: 0001194020
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35518
FILM NUMBER: 22674074
MAIL ADDRESS:
STREET 1: C/O OPGEN, INC.
STREET 2: 708 QUINCE ORCHARD ROAD, SUITE 205
CITY: GAITHERSBURG
STATE: MD
ZIP: 20878
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: SUPERNUS PHARMACEUTICALS, INC.
CENTRAL INDEX KEY: 0001356576
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 9715 KEY WEST AVENUE
CITY: ROCKVILLE
STATE: MD
ZIP: 20850
BUSINESS PHONE: 301-838-2500
MAIL ADDRESS:
STREET 1: 9715 KEY WEST AVENUE
CITY: ROCKVILLE
STATE: MD
ZIP: 20850
FORMER COMPANY:
FORMER CONFORMED NAME: SUPERNUS PHARMACEUTICALS INC
DATE OF NAME CHANGE: 20060317
4
1
tm227622-5_4seq1.xml
OWNERSHIP DOCUMENT
X0306
4
2022-02-22
0
0001356576
SUPERNUS PHARMACEUTICALS, INC.
SUPN
0001194020
DEC TIMOTHY C
C/O SUPERNUS PHARMACEUTICALS, INC.
9715 KEY WEST AVENUE
ROCKVILLE
MD
20850
0
1
0
0
Senior Vice-President & CFO
Employee Stock Option (Right to Buy)
32.20
2022-02-22
4
A
0
25000
0
A
2032-02-22
Common Stock
25000
25000
D
Restricted Stock Units
2022-02-22
4
A
0
2000
0
A
Common Stock
2000
2000
D
The option vests in four equal annual installments beginning on February 22, 2023.
Each restricted stock unit represents the right to receive one share of Supernus common stock upon vesting.
These restricted stock units will be settled in common stock upon vesting, such vesting to occur on February 22, 2023.
/s/ Timothy C. Dec
2022-02-24